BC
Bicara Therapeutics Inc. Common Stock (BCAX)
NASDAQ·Healthcare·Biotechnology
$22.72
+0.58%
Mkt Cap $1.45B
Analyst Ratings
Buy
6
Hold
6
Sell
0
Price Target (10 analysts)
$32.33
Range $18.00 – $42.00
Implied Upside
+42.3%
Consensus $32.33 vs current $22.72